Morepen Laboratories has clarified that the company has been regularly intimating all the compliances to Stock Exchanges as per Regulation 30 of the SEBI (LODR) Regulations, 2015 as amended. The Company has confirmed that there are no pending announcements, events or information which is/ are price sensitive that could have led to significant increase in volume in the company's shares. The increase in volume of the shares may be market driven.
The above information is a part of company’s filings submitted to BSE.
